Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;123(3):368-75.
doi: 10.1111/1471-0528.13744. Epub 2015 Nov 6.

Pharmacogenomics of preterm birth prevention and treatment

Affiliations
Review

Pharmacogenomics of preterm birth prevention and treatment

T A Manuck. BJOG. 2016 Feb.

Abstract

Pharmacogenomics and personalised medicine incorporate genetic factors, historical data, and environmental exposures to predict individual variation in response to medications. The study of pharmacology and pharmacogenomics is challenging in obstetrics, and our knowledge in this area lags behind other disciplines of medicine. Some preliminary data, however, suggest that some of the interindividual variation seen in response to medications given for the prevention (progesterone) and the treatment (nifedipine, terbutaline, and others) of preterm labour may be caused by pharmacogenomic effects. A comprehensive approach, integrating clinical data, environmental factors, including concomitant medications and genotype, to optimise the prevention and treatment strategies for preterm birth, is urgently needed.

Tweetable abstract: Some of the variation to meds for prematurity prevention/treatment may arise from pharmacogenomic effects.

Keywords: Personalised medicine; pharmacogenomics; prematurity prevention; preterm birth; progesterone; tocolysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a. Schematic of traditional medication prescribing b. Schematic of medication prescribing in an era of personalized medicine.
Figure 1
Figure 1
a. Schematic of traditional medication prescribing b. Schematic of medication prescribing in an era of personalized medicine.

References

    1. Shastry BS. Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J. 2006;6(1):16–21. - PubMed
    1. Smyth RM, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children--a systematic review. PLoS One. 2012;7(3):e24061. - PMC - PubMed
    1. Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC medicine. 2013;11:237. - PMC - PubMed
    1. Khan LM. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review. Eur J Clin Pharmacol. 2013;69(12):1985–1996. - PubMed
    1. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov. 2007;6(4):287–293. - PubMed

Publication types

LinkOut - more resources